147 related articles for article (PubMed ID: 15314491)
21. Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development.
Choi MY; Costenbader KH
Front Immunol; 2022; 13():890522. PubMed ID: 35720390
[TBL] [Abstract][Full Text] [Related]
22. Interferons in Systemic Lupus Erythematosus.
Sirobhushanam S; Lazar S; Kahlenberg JM
Rheum Dis Clin North Am; 2021 Aug; 47(3):297-315. PubMed ID: 34215365
[TBL] [Abstract][Full Text] [Related]
23. Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():662901. PubMed ID: 34093553
[TBL] [Abstract][Full Text] [Related]
24. Assessing the Function of the
Zhu T; Huang Y; Qian D; Sheng Y; Zhang C; Chen S; Zhang H; Wang H; Zhang X; Liu J; Ding C; Liu L
Front Immunol; 2021; 12():611515. PubMed ID: 33796098
[TBL] [Abstract][Full Text] [Related]
25. Belimumab for systemic lupus erythematosus.
Singh JA; Shah NP; Mudano AS
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD010668. PubMed ID: 33631841
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D and connective tissue diseases.
Berardi S; Giardullo L; Corrado A; Cantatore FP
Inflamm Res; 2020 May; 69(5):453-462. PubMed ID: 32172354
[TBL] [Abstract][Full Text] [Related]
27. Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation.
Godavarthy A; Kelly R; Jimah J; Beckford M; Caza T; Fernandez D; Huang N; Duarte M; Lewis J; Fadel HJ; Poeschla EM; Banki K; Perl A
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31805010
[TBL] [Abstract][Full Text] [Related]
28. Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications.
Grygiel-Górniak B; Rogacka N; Puszczewicz M
Reumatologia; 2018; 56(4):243-248. PubMed ID: 30237629
[TBL] [Abstract][Full Text] [Related]
29. The complement system as a potential therapeutic target in rheumatic disease.
Trouw LA; Pickering MC; Blom AM
Nat Rev Rheumatol; 2017 Sep; 13(9):538-547. PubMed ID: 28794515
[TBL] [Abstract][Full Text] [Related]
30. Serum level of DNase1l3 in patients with dermatomyositis/polymyositis, systemic lupus erythematosus and rheumatoid arthritis, and its association with disease activity.
Zhao Q; Yang C; Wang J; Li Y; Yang P
Clin Exp Med; 2017 Nov; 17(4):459-465. PubMed ID: 28039554
[TBL] [Abstract][Full Text] [Related]
31. Spatiotemporal Regulation of Hsp90-Ligand Complex Leads to Immune Activation.
Tamura Y; Yoneda A; Takei N; Sawada K
Front Immunol; 2016; 7():201. PubMed ID: 27252703
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptors: potential targets for lupus treatment.
Wu YW; Tang W; Zuo JP
Acta Pharmacol Sin; 2015 Dec; 36(12):1395-407. PubMed ID: 26592511
[TBL] [Abstract][Full Text] [Related]
33. Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis.
Wampler Muskardin T; Vashisht P; Dorschner JM; Jensen MA; Chrabot BS; Kern M; Curtis JR; Danila MI; Cofield SS; Shadick N; Nigrovic PA; St Clair EW; Bingham CO; Furie R; Robinson W; Genovese M; Striebich CC; O'Dell JR; Thiele GM; Moreland LW; Levesque M; Bridges SL; Gregersen PK; Niewold TB
Ann Rheum Dis; 2016 Oct; 75(10):1757-62. PubMed ID: 26546586
[TBL] [Abstract][Full Text] [Related]
34. The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression.
Hung T; Pratt GA; Sundararaman B; Townsend MJ; Chaivorapol C; Bhangale T; Graham RR; Ortmann W; Criswell LA; Yeo GW; Behrens TW
Science; 2015 Oct; 350(6259):455-9. PubMed ID: 26382853
[TBL] [Abstract][Full Text] [Related]
35. Minimal Change Disease as a Secondary and Reversible Event of a Renal Transplant Case with Systemic Lupus Erythematosus.
Gkrouzman E; Kirou KA; Seshan SV; Chevalier JM
Case Rep Nephrol; 2015; 2015():987212. PubMed ID: 26351598
[TBL] [Abstract][Full Text] [Related]
36. Targeting the inflammasome in rheumatic diseases.
McCoy SS; Stannard J; Kahlenberg JM
Transl Res; 2016 Jan; 167(1):125-37. PubMed ID: 26118952
[TBL] [Abstract][Full Text] [Related]
37. Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.
Amarasekara DS; Yu J; Rho J
J Immunol Res; 2015; 2015():832127. PubMed ID: 26065006
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial DNA stress primes the antiviral innate immune response.
West AP; Khoury-Hanold W; Staron M; Tal MC; Pineda CM; Lang SM; Bestwick M; Duguay BA; Raimundo N; MacDuff DA; Kaech SM; Smiley JR; Means RE; Iwasaki A; Shadel GS
Nature; 2015 Apr; 520(7548):553-7. PubMed ID: 25642965
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors.
Cates AM; Holden VI; Myers EM; Smith CK; Kaplan MJ; Kahlenberg JM
Rheumatology (Oxford); 2015 Jun; 54(6):1114-23. PubMed ID: 25416712
[TBL] [Abstract][Full Text] [Related]
40. Type I interferon in the pathogenesis of lupus.
Crow MK
J Immunol; 2014 Jun; 192(12):5459-68. PubMed ID: 24907379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
